Cargando…
A Novel Prognostic Signature Associated with Immunotherapeutic Response for Hepatocellular Carcinoma
BACKGROUND: Although accumulating literature has validated that necroptosis plays a prominent role in the tumorigenesis and progression of various malignant cancer, its mechanism in hepatocellular carcinoma (HCC) is poorly understood. Therefore, in the present study, we want to study the impact of n...
Autores principales: | Jin, Xinmin, Wang, Jinhuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294469/ https://www.ncbi.nlm.nih.gov/pubmed/35865037 http://dx.doi.org/10.3389/fsurg.2022.905897 |
Ejemplares similares
-
Comprehensive Analysis to Identify the Epithelial–Mesenchymal Transition-Related Immune Signatures as a Prognostic and Therapeutic Biomarkers in Hepatocellular Carcinoma
por: Wu, Guozhi, et al.
Publicado: (2021) -
Molecular subtypes, prognostic and immunotherapeutic relevant gene signatures mediated by DNA methylation regulators in hepatocellular carcinoma
por: Shi, Rongfeng, et al.
Publicado: (2022) -
Development and validation of a prognostic and immunotherapeutically relevant model in hepatocellular carcinoma
por: Wang, Yu, et al.
Publicado: (2020) -
Prognostic model of immune-related genes for patients with hepatocellular carcinoma
por: Cai, Qun, et al.
Publicado: (2022) -
Immunotherapeutic approaches for hepatocellular carcinoma
por: Longo, Vito, et al.
Publicado: (2017)